Viveve Medical (NASDAQ:VIVE Get Rating) was downgraded by research analysts at Alliance Global Partners from a buy rating to a neutral rating in a report released on Monday, The Fly reports. Viveve Medical Stock Performance Shares of NASDAQ VIVE opened at $0.10 on...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
The post Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on ...
Study's primary efficacy endpoint was not achieved at 12 months post-treatmentCompany has implemented a reduction in forceCompany will seek strategic alternatives and will be delisted from Nasdaq ENGLEWOOD, CO / ACCESSWIRE / January 17, 2023 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical...
Viveve Medical, Inc. (NASDAQ:VIVE Get Rating) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 213,700 shares, a growth of 20.0% from the November 30th total of 178,100 shares. Based on an average daily volume of...
Viveve Medical, Inc. (NASDAQ:VIVE Get Rating) saw a significant increase in short interest in November. As of November 30th, there was short interest totalling 178,100 shares, an increase of 98.8% from the November 15th total of 89,600 shares. Based on an average daily volume of 22,900 ...
Viveve Medical, Inc. (NASDAQ:VIVE Get Rating) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 89,600 shares, a growth of 62.0% from the October 31st total of 55,300 shares. Based on an average ...
Total revenue of $1.7 million in Q3 including sale of 3,100 disposable treatment tipsPURSUIT clinical trial completion expected by year-endConference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / November 10, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical...